NFG
NVCT icon

Nations Financial Group’s Nuvectis Pharma NVCT Stock Holding History

Nations Financial Group’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,000
Closed -$100K – 821
2026
Q1 		$100K Hold
13,000
– – 0.01% 761
2025
Q4 		$98.2K Hold
13,000
– – 0.01% 739
2025
Q3 		$78.3K Hold
13,000
– – ﹤0.01% 703
2025
Q2 		$97.1K Sell
13,000
-500
-4% -$4.53K 0.01% 672
2025
Q1 		$132K Hold
13,500
– – 0.01% 639
2024
Q4 		$73K Buy
13,500
+3,500
+35% +$21.9K 0.01% 657
2024
Q3 		$62.9K Buy
+10,000
New +$65.8K ﹤0.01% 663

Other funds holding NVCT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

Nations Financial Group's NVCT Position: Q2 2026 in Review

Nations Financial Group sold out of Nuvectis Pharma (NVCT) in Q2 2026, closing a stake of 13,000 shares — an estimated $100K sold.

Nations Financial Group first reported a position in NVCT in Q3 2024 and held it in 7 quarters. The position peaked at $132K in Q1 2025. 83 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • Nations Financial Group reported no remaining Nuvectis Pharma position as of Q2 2026 after selling out during the quarter.
  • Nations Financial Group sold 13,000 Nuvectis Pharma shares in Q2 2026, an estimated $100K.
  • Nations Financial Group first reported a position in Nuvectis Pharma in Q3 2024 and held it in 7 quarters.
  • Nations Financial Group's Nuvectis Pharma position peaked at $132K in Q1 2025.
  • 83 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on Nations Financial Group's 13F filing for Q2 2026, filed 23 Jul 2026.